These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Distinct variant of Sweet's syndrome: bortezomib-induced histiocytoid Sweet's syndrome in a patient with multiple myeloma. Kim JS; Roh HS; Lee JW; Lee MW; Yu HJ Int J Dermatol; 2012 Dec; 51(12):1491-3. PubMed ID: 22998496 [No Abstract] [Full Text] [Related]
9. Sweet-like lesions induced by bortezomib: a review of the literature and a report of 2 cases. Truchuelo M; Bagazgoitia L; Alcántara J; Velasco D; Carrillo R Actas Dermosifiliogr; 2012 Nov; 103(9):829-31. PubMed ID: 22652505 [No Abstract] [Full Text] [Related]
10. Bortezomib in multiple myeloma. Mateos MV; San Miguel JF Best Pract Res Clin Haematol; 2007 Dec; 20(4):701-15. PubMed ID: 18070714 [TBL] [Abstract][Full Text] [Related]
11. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Badros A; Goloubeva O; Dalal JS; Can I; Thompson J; Rapoport AP; Heyman M; Akpek G; Fenton RG Cancer; 2007 Sep; 110(5):1042-9. PubMed ID: 17654660 [TBL] [Abstract][Full Text] [Related]